Vulnerability Description
A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Cisco | Duo Device Health Application | >= 5.0.0, < 5.2.0 |
Related Weaknesses (CWE)
References
- https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/ciPatchVendor Advisory
- https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/ciPatchVendor Advisory
FAQ
What is CVE-2023-20229?
CVE-2023-20229 is a vulnerability with a CVSS score of 7.1 (HIGH). A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks...
How severe is CVE-2023-20229?
CVE-2023-20229 has been rated HIGH with a CVSS base score of 7.1/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-20229?
Check the references section above for vendor advisories and patch information. Affected products include: Cisco Duo Device Health Application.